Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Aehr Test Systems stock logo
AEHR
Aehr Test Systems
$15.51
+2.5%
$10.53
$6.27
$21.44
$464.43M2.291.20 million shs1.63 million shs
Cytek Biosciences, Inc. stock logo
CTKB
Cytek Biosciences
$3.76
+4.2%
$3.19
$2.37
$7.63
$476.24M1.33824,273 shs776,901 shs
Senseonics Holdings, Inc. stock logo
SENS
Senseonics
$0.50
+1.8%
$0.56
$0.25
$1.40
$326.45M0.927.14 million shs2.51 million shs
Transcat, Inc. stock logo
TRNS
Transcat
$89.88
+1.2%
$82.99
$67.56
$147.12
$837.47M0.7390,707 shs41,764 shs
7 Stocks to Buy And Hold Forever Cover

Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Aehr Test Systems stock logo
AEHR
Aehr Test Systems
0.00%+23.88%+40.24%+113.64%+41.00%
Cytek Biosciences, Inc. stock logo
CTKB
Cytek Biosciences
0.00%+5.92%+12.57%+1.35%-32.50%
Senseonics Holdings, Inc. stock logo
SENS
Senseonics
0.00%+0.99%-5.55%-12.85%+27.36%
Transcat, Inc. stock logo
TRNS
Transcat
0.00%+5.97%+12.04%+19.47%-26.82%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Aehr Test Systems stock logo
AEHR
Aehr Test Systems
4.03 of 5 stars
3.53.00.00.01.72.53.1
Cytek Biosciences, Inc. stock logo
CTKB
Cytek Biosciences
3.0377 of 5 stars
3.14.00.00.02.24.20.0
Senseonics Holdings, Inc. stock logo
SENS
Senseonics
1.5553 of 5 stars
3.81.00.00.01.10.00.6
Transcat, Inc. stock logo
TRNS
Transcat
2.823 of 5 stars
3.33.00.00.02.01.71.3
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Aehr Test Systems stock logo
AEHR
Aehr Test Systems
3.00
Buy$25.0061.19% Upside
Cytek Biosciences, Inc. stock logo
CTKB
Cytek Biosciences
2.20
Hold$5.6048.94% Upside
Senseonics Holdings, Inc. stock logo
SENS
Senseonics
3.50
Strong Buy$1.55210.62% Upside
Transcat, Inc. stock logo
TRNS
Transcat
2.50
Moderate Buy$114.0026.84% Upside

Current Analyst Ratings Breakdown

Latest AEHR, TRNS, CTKB, and SENS Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
6/25/2025
Transcat, Inc. stock logo
TRNS
Transcat
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$116.00
6/2/2025
Senseonics Holdings, Inc. stock logo
SENS
Senseonics
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Set Price TargetBuy$1.10
5/28/2025
Cytek Biosciences, Inc. stock logo
CTKB
Cytek Biosciences
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetEqual Weight ➝ Equal Weight$9.00 ➝ $7.00
5/21/2025
Transcat, Inc. stock logo
TRNS
Transcat
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$106.00 ➝ $116.00
5/12/2025
Cytek Biosciences, Inc. stock logo
CTKB
Cytek Biosciences
The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetSell ➝ Sell$3.50 ➝ $3.00
5/9/2025
Cytek Biosciences, Inc. stock logo
CTKB
Cytek Biosciences
TD Cowen
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeBuy ➝ Hold$4.00
4/10/2025
Senseonics Holdings, Inc. stock logo
SENS
Senseonics
Mizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageOutperform$2.00
4/9/2025
Senseonics Holdings, Inc. stock logo
SENS
Senseonics
Mizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeStrong-Buy
(Data available from 7/6/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Aehr Test Systems stock logo
AEHR
Aehr Test Systems
$66.22M6.97$1.19 per share13.03$3.86 per share4.02
Cytek Biosciences, Inc. stock logo
CTKB
Cytek Biosciences
$200.45M2.38$0.03 per share108.35$3.07 per share1.22
Senseonics Holdings, Inc. stock logo
SENS
Senseonics
$23.68M13.78N/AN/A$0.07 per share7.13
Transcat, Inc. stock logo
TRNS
Transcat
$278.42M3.01$4.27 per share21.06$30.82 per share2.92
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Aehr Test Systems stock logo
AEHR
Aehr Test Systems
$33.16M$0.7819.8870.50N/A37.17%21.15%18.13%7/15/2025 (Estimated)
Cytek Biosciences, Inc. stock logo
CTKB
Cytek Biosciences
-$6.02M-$0.09N/AN/A-5.71%-2.90%-2.30%8/5/2025 (Estimated)
Senseonics Holdings, Inc. stock logo
SENS
Senseonics
-$60.39M-$0.11N/AN/AN/A-362.30%-842.25%-67.99%N/A
Transcat, Inc. stock logo
TRNS
Transcat
$14.52M$1.5657.6234.17N/A5.21%6.47%5.02%8/4/2025 (Estimated)

Latest AEHR, TRNS, CTKB, and SENS Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
7/15/2025Q4 2025
Aehr Test Systems stock logo
AEHR
Aehr Test Systems
-$0.0150N/AN/AN/A$14.83 millionN/A
5/19/2025Q4 2025
Transcat, Inc. stock logo
TRNS
Transcat
$0.66$0.64-$0.02$0.48$76.40 million$77.13 million
5/8/2025Q1 2025
Cytek Biosciences, Inc. stock logo
CTKB
Cytek Biosciences
-$0.04-$0.09-$0.05-$0.09$43.18 million$41.46 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Aehr Test Systems stock logo
AEHR
Aehr Test Systems
N/AN/AN/AN/AN/A
Cytek Biosciences, Inc. stock logo
CTKB
Cytek Biosciences
N/AN/AN/AN/AN/A
Senseonics Holdings, Inc. stock logo
SENS
Senseonics
N/AN/AN/AN/AN/A
Transcat, Inc. stock logo
TRNS
Transcat
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Aehr Test Systems stock logo
AEHR
Aehr Test Systems
N/A
5.71
3.07
Cytek Biosciences, Inc. stock logo
CTKB
Cytek Biosciences
N/A
5.62
4.95
Senseonics Holdings, Inc. stock logo
SENS
Senseonics
59.17
2.47
2.38
Transcat, Inc. stock logo
TRNS
Transcat
0.11
2.29
1.87

Institutional Ownership

CompanyInstitutional Ownership
Aehr Test Systems stock logo
AEHR
Aehr Test Systems
69.69%
Cytek Biosciences, Inc. stock logo
CTKB
Cytek Biosciences
69.46%
Senseonics Holdings, Inc. stock logo
SENS
Senseonics
12.36%
Transcat, Inc. stock logo
TRNS
Transcat
98.34%

Insider Ownership

CompanyInsider Ownership
Aehr Test Systems stock logo
AEHR
Aehr Test Systems
6.20%
Cytek Biosciences, Inc. stock logo
CTKB
Cytek Biosciences
10.33%
Senseonics Holdings, Inc. stock logo
SENS
Senseonics
4.30%
Transcat, Inc. stock logo
TRNS
Transcat
2.30%
CompanyEmployeesShares OutstandingFree FloatOptionable
Aehr Test Systems stock logo
AEHR
Aehr Test Systems
9029.77 million27.93 millionOptionable
Cytek Biosciences, Inc. stock logo
CTKB
Cytek Biosciences
500126.66 million113.58 millionOptionable
Senseonics Holdings, Inc. stock logo
SENS
Senseonics
90654.22 million573.90 millionN/A
Transcat, Inc. stock logo
TRNS
Transcat
1,2459.32 million9.10 millionOptionable

Recent News About These Companies

HC Wainwright Has Positive Forecast for Transcat Q2 Earnings

New MarketBeat Followers Over Time

Media Sentiment Over Time

Aehr Test Systems stock logo

Aehr Test Systems NASDAQ:AEHR

$15.51 +0.38 (+2.51%)
Closing price 07/3/2025 03:58 PM Eastern
Extended Trading
$15.61 +0.10 (+0.64%)
As of 07/3/2025 04:58 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Aehr Test Systems provides test solutions for testing, burning-in, and semiconductor devices in wafer level, singulated die, and package part form, and installed systems worldwide. Its product portfolio includes FOX-XP and FOX-NP systems that are full wafer contact and singulated die/module test and burn-in systems that can test, burn-in, and stabilize range of devices, including silicon carbide-based and other power semiconductors, 2D and 3D sensors used in mobile phones, tablets and other computing devices, memory semiconductors, processors, microcontrollers, systems-on-a-chip, and photonics and integrated optical devices. The company also offers FOX-CP system, a low-cost single-wafer compact test solution for logic, memory, and photonic devices; FOX WaferPak Contactor, a full wafer contactor capable of testing wafers up to 300mm that enables integrated circuit manufacturers to perform test, burn-in, and stabilization of full wafers on the FOX-P systems. In addition, it provides FOX DiePak Carrier, a reusable temporary package that enables IC manufacturers to perform final test and burn-in of bare die and modules; and FOX DiePak Loader. The company was incorporated in 1977 and is headquartered in Fremont, California.

Cytek Biosciences stock logo

Cytek Biosciences NASDAQ:CTKB

$3.76 +0.15 (+4.16%)
Closing price 07/3/2025 01:23 PM Eastern
Extended Trading
$3.76 0.00 (0.00%)
As of 07/3/2025 04:20 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitates scientific advances in biomedical research and clinical applications. It offers aurora and northern lights systems, which are spectrum flow cytometers that delivers cell analysis by utilizing the fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells; and aurora cell sorter system that leverages full spectrum profiling technology to further broaden potential applications across cell analysis; aurora CS systems; amnis imagestream imaging flow cytometers; guava muse cell analyzers; guava easycyte flow cytometers; and orion reagent cocktail preparation systems. The company also provides reagents and kits, including cFluor reagents that are fluorochrome conjugated antibodies used to identify cells of interest for analysis on its instruments, as well as 25-color immunoprofiling assay that provides turnkey solutions for identifying major human immune subpopulations for TBNK cells, monocytes, dendritic cells, and basophils. In addition, it offers automated micro-sampling system and automated sample loader system, an automated loaders to integrate seamlessly into the aurora and northern lights systems; SpectroFlo software that provides intuitive workflow from quality control to data analysis for aurora and northern lights systems; and customer support tools. The company serves pharmaceutical and biopharma companies, academic research centers, and clinical research organizations. It distributes its products through direct sales force and support organizations in North America, Europe, China, and the Asia-Pacific regions; and through distributors or sales agents in European, Latin American, and the Middle Eastern countries. The company was formerly known as Cytoville, Inc. and changed its name to Cytek Biosciences, Inc. in August 2015. Cytek Biosciences, Inc. was founded in 1992 and is headquartered in Fremont, California.

Senseonics stock logo

Senseonics NYSE:SENS

$0.50 +0.01 (+1.84%)
Closing price 07/3/2025 03:54 PM Eastern
Extended Trading
$0.50 +0.00 (+0.20%)
As of 07/3/2025 04:54 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Senseonics Holdings, Inc., a medical technology company, focuses on development and manufacturing of continuous glucose monitoring (CGM) systems for people with diabetes in the United States and internationally. The company's products include Eversense, Eversense XL, and Eversense E3 that are implantable CGM systems to measure glucose levels in people with diabetes through an under-the-skin sensor, a removable and rechargeable smart transmitter, and a convenient app for real-time diabetes monitoring and management. It serves healthcare providers and patients through a network of distributors and strategic fulfillment partners. Senseonics Holdings, Inc. was founded in 1996 and is headquartered in Germantown, Maryland.

Transcat stock logo

Transcat NASDAQ:TRNS

$89.88 +1.03 (+1.16%)
As of 07/3/2025 01:04 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Transcat, Inc. provides calibration and laboratory instrument services in the United States, Canada, and internationally. It operates through two segments: Service and Distribution. The Service segment offers calibration, repair, inspection, analytical qualification, preventative maintenance, consulting, and other related services. This segment also provides CalTrak, a proprietary document and asset management system that is used to manage the workflow of its calibration service centers and customers' assets; and Compliance, Control and Cost, an online customer portal that provides its customers with web-based asset management capability, as well as a safe and secure off-site archive of calibration and other service records. The Distribution segment sells and rents test, measurement, and control instruments for customers' test and measurement instrumentation needs, as well as value added services, such as calibration/certification of equipment purchase, equipment rental, used equipment for sale, and equipment kitting. This segment markets and sells its products through website, digital and print advertising, proactive outbound sales, and an inbound call center. The company provides services and products to highly regulated industries, principally life science, which includes companies in the pharmaceutical, biotechnology, medical device, and other FDA-regulated industries; and additional industries, including aerospace and defense industrial manufacturing, energy and utilities, and other industries that require accuracy in processes and confirmation of the capabilities of their equipment. Transcat, Inc. was incorporated in 1964 and is headquartered in Rochester, New York.